|
Date |
Contents |
|
2020 |
US FDA approved HD-6277 phase 2 IND for the treatment of type2 diabetes.
|
|
2019 |
Acquired ISO 37001 Certification
|
|
2019 |
Research contract for the "development of soft tissue-hardening compounds"
|
|
2019 |
American Diabetes Association (ADA) - Poster presentation of the result for the Phase 1 clinical trial of new anti-diabetes drug
|
|
2019 |
To achieve accident-free eight multiple(3,764 days)
|
|
2018 |
Compliance Program grade "AA" acquisition by Fair Trade Commission compliance program.
|
|
2018 |
5th Certificate of Consumer-Centered Management
|
|
2018 |
Sulfolase CR Tab. release
|
|
2017 |
Re-Certificate for excellence organization in Arts Council Korea
|
|
2017 |
'Sang-Jun, Lee', inaugurated as President
|
|
2017 |
'ArtMplus' Recertification for excellence organization in Arts Council Korea
|
|
2017 |
European Association for the study of Diabetes(EASD) - Poster presentation
|
|
2017 |
'The 50th Occupational health and safety's Day', Awarded for a man of merit Accident Prevention
|
|
2017 |
American Diabetes Association(ADA) - Poster presentation
|
|
2017 |
HD-6277(Candidiate Material of Diabets New Durg) has been approved the phase 1 clinical trial in Euroup.
|
|
2016 |
Recertification for Consumer Centered Management (CCM)
|
|
2016 |
Acquired the certificate of exellence laboratory for Safety management hosted Ministry of Science and ICT
|
|
2016 |
Selected as Continuity task for development of Diabets new drug
|
|
2016 |
'Aslan001' Designation of Orphan Drug in FDA
|
|
2016 |
Delivery of the relief medicine Worth KRW 1.3 billion for earthquake damage in Ecuadore
|
|
2015 |
'The 20th Consumer's day' Commendation of Fair Trade Commissioner
|
|
2015 |
'IP-R&D excellence organization' Prime the minister award of Ministry of Trade, Industry and Energy
|
|
2015 |
Prime the silver prize in the national president in National Quality Management Congress
|
|
2015 |
Contract the Technical introduction of gallbladder cancer medicine
|
|
2015 |
Hold Concert of Menopause Day
|
|
2015 |
Apply the Composition patent of Tranexamic acid externals at 10 countries abroad |
|
2015 |
Development of candidiate Material of New Durg for Type 2 diabetes targeting GPR119 receptor |
|
2015 |
Levotuss CR tab. Start up the Phase 3 Clinical trial |
|
2015 |
Hyundai Pharmaceutical Co., LTD. Technical tranfer agreement with University-Industry Cooperation Foundation, Konkuk University |
|
2015 |
Certificate for excellence organization in Arts Council Korea |
|
2014 |
Commendation of Fair Trade Commissioner in CCM sector for the first in the pharmaceutical industry |
|
2014 |
¡®HD-2356¡¯ has been selected as a project supported by the Ministry of Health & Welfare |
|
2014 |
Hyundai Pharmaceutical Co., Ltd. signed license-out and supply agreement of Surfolase with Novotek, China |
|
2013 |
'Young-Hak, Kim', inaugurated as President |
|
2013 |
¡®HD-6277(GPR40 agonist)¡¯ has been selected as a project supported by the government |
|
2013 |
¡®Choline alfoscerate SR¡¯ has been selected as one of projects supported by Ministry of Health and Welfare. |
|
2013 |
Registed of patent for Levotuss (Levodropropizine) CR tablet |
|
2012 |
Sulforase CR tablet was selected for R&D support project by the Ministry of Health & Welfare |
|
2012 |
Recertification for Consumer Centered Management (CCM) |
|
2012 |
Hyundai Pharmaceutical Co., LTD. signed the marketing and sales agreement of TachoSil® |
|
2012 |
Signed technology transfer agreeemnt to Europe for Pramipexole sustained release tablet |
|
2012 |
Selected as innovative pharmaceutical company by Ministry of Health & Welfare |
|
2012 |
Designated as ATC (Advanced Technology Center) by Ministry of Knowledge Economy for development of new pharmaceutical products. |
|
2012 |
Signed technology transfer agreement for new molecule of anti-obesity with Yonsei University |
|
2011 |
Hit 15,000 of Noksaekjikimi (³ì»öÁöÅ´ÀÌ), Hyundai's suggestion system for innovation |
|
2011 |
Signed co-promotion agreement of Ocuvite with BauschLomb |
|
2011 |
Signed license-in agreement of Ruping eye drop (artificial tear) with Ophtecs corp, Japan |
|
2011 |
Established a new R&D center in Yongin-si |
|
2011 |
Made an agreement to donate for culture promotion with ¡®Art Council Korea¡¯ |
|
2011 |
Took out a patent for ingredient of hypertension |
|
2010 |
Recertification for Consumer Complaints Management System (CCMS) |
|
2010 |
Made an agreement about home sales for ¡®Natto Balance¡¯ with ¡®Nitto Pharmaceutical Industries of Japan¡¯ |
|
2010 |
Made an agreement about home sales for ¡®Nasalguard¡¯ with ¡®Nitto Pharmaceutical Industries of Japan¡¯ |
|
2010 |
Made an agreement about tie-in promotion with ¡®Merck of Germany¡¯ |
|
2010 |
Made the move to an office building located in Gangnam-gu |
|
2010 |
Our CEO, ¡®Han-Koo Lee¡¯ was awarded the 47th prize of Dong-am¡¯s drugs |
|
2010 |
Were chosen again as the best company of management for the risk of fire (from Korean Fire Protection Association) |
|
2009 |
Our CEO, ¡®Han-Koo Lee¡¯ was awarded the Silver Industrial Medal by the government (from the 35th national competition of quality management) |
|
2009 |
Over 10,000 about keeping safety |
|
2009 |
Launched ¡®Tamirin TAB¡¯ which is a medicine for Alzheimer (for the first time in a domestic market) |
|
2009 |
Signed the MOU regarding informing correct pharmaceutical information on the Internet with ¡®DAUM¡¯ |
|
2009 |
Got an approval from ¡®Korea Food and Drug Administration¡¯ regarding the clinical trial of HD-003, a new medicine |
|
2009 |
Were chosen as the best company of management for the risk of fire (from Korean Fire Protection Association) |
|
2009 |
Made an agreement about co-development for HFT-401, a new medicine for arthritis, with Forhumantech |
|
2009 |
Established a new R&D center in Bio center in Gyeonggi-do |
|
2008 |
Received a President Award in National Quality Management Competition and CCMS (Consumer Complaints Management System) certification. (1st time in Korean Pharmaceutical Industry) |
|
2007 |
Changed Corporate Identity (CI) |
|
2006 |
Awarded a grand prize for management value by Korean Government |
|
2005 |
2005 Awarded for safe management by the National President
(top honor given by Korean Government) |
|
2002 |
Construction of New Factory (Wall-San Factory)
Research funding at University of Glasgow and University of
Strathclyde |
|
2001 |
Acquired ISO 14001 certificate
Invested to take stake to Korean Biotech Company (A&Pep,
MedexBio) |
|
2000 |
Acquired ISO 9001 certificate
Invested to take stake to Korean Biotech Company (Biobud) |
|
1999 |
Acquired worldwide patent for NSC-peptide synthesis |
|
1997 |
Elected Best Productivity Company Among All Listed Companies
in Korea |
|
1993 |
1993 Built a Plant at Hap-Cheon (Health Food Drink) |
|
1989 |
Started Production of Health Food Drink |
|
1985 |
Completed KGMP Plant at Cheon-Ahn (Pharmaceuticals) |
|
1984 |
Awarded for Best Enterprise by Korea Management Association |
|
1978 |
Listed at Korean Stock Market |
|
1973 |
Changed Corporate Name to Hyundai Pharmaceutical Ind. Co.,
Ltd. |
|
1965 |
Founded Hyundai Disinfection Chemical Ind. Co., Ltd |
|